Compare CFND & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CFND | YI |
|---|---|---|
| Founded | N/A | 2010 |
| Country | | China |
| Employees | N/A | N/A |
| Industry | | Retail-Drug Stores and Proprietary Stores |
| Sector | | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.5M | 38.1M |
| IPO Year | 2025 | N/A |
| Metric | CFND | YI |
|---|---|---|
| Price | $5.31 | $3.75 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | N/A | ★ 11.5K |
| Earning Date | N/A | 12-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,979,883,442.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | N/A | $3.19 |
| 52 Week High | N/A | $11.35 |
| Indicator | CFND | YI |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 40.75 |
| Support Level | N/A | $3.60 |
| Resistance Level | N/A | $3.88 |
| Average True Range (ATR) | 0.00 | 0.19 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 0.00 | 69.51 |
C1 Fund Inc is a non-diversified, closed-end management investment company designed to give investors access to the private digital asset ecosystem. Its investment objective is to maximize its portfolio's total return. The fund targets a handpicked portfolio of the late-stage private companies driving the future of digital asset services and technology. It offers early access to the next generation of category-defining companies and aims to bridge the gap between public and private markets and give investors access to the private companies with the safeguards of a NYSE listed fund that is regulated and liquid.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.